Related references
Note: Only part of the references are listed.Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis
Andras Garami et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Modulation of TRPV1 channel function by natural products in the treatment of pain
Manal Ahmad Abbas
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
TRPV1 Modulators for the Treatment of Pain and Inflammation
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2019)
TRPV1 pore turret dictates distinct DkTx and capsaicin gating
Matan Geron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action
Yuan Gao et al.
NATURE (2016)
TRPV1: A Target for Rational Drug Design
Vincenzo Carnevale et al.
PHARMACEUTICALS (2016)
Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel
Fan Yang et al.
NATURE CHEMICAL BIOLOGY (2015)
TRPV1 structures in distinct conformations reveal activation mechanisms
Erhu Cao et al.
NATURE (2013)
Structure of the TRPV1 ion channel determined by electron cryo-microscopy
Maofu Liao et al.
NATURE (2013)
Multisteric TRPV1 nocisensor: a target for analgesics
Janos Szolcsanyi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception
Michael R. Brandt et al.
PHARMACEUTICALS (2012)
Structure-Activity Relationship of Capsaicin Analogs and Transient Receptor Potential Vanilloid 1-Mediated Human Lung Epithelial Cell Toxicity
Karen C. Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats
Sonya G. Lehto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
Narender R. Gavva et al.
PAIN (2008)
Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers
Alexander M. Binshtok et al.
NATURE (2007)
Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway
DP Mohapatra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1)
G Bhave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of vanilloid receptor 1 (VR1) by eugenol
BH Yang et al.
JOURNAL OF DENTAL RESEARCH (2003)
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
P McIntyre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Acid potentiation of the capsaicin receptor determined by a key extracellular site
SE Jordt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
